CDKN2C and breast cancer: This cell line shares many genetic (p16/p18 and Brca1 loss-of-function mutation) and phenotypical (ER negative with a subset of cells exhibiting EMT features) similarities with p16;Brca1 and p18;Brca1 mutant murine mammary tumor cells.